Tyra Biosciences, Inc. (TYRA)
Last updated: 2026-10-20 19:42:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Tyra Biosciences, Inc. (TYRA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $20.45, with a market capitalization of $1.27B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.35 to $40.65. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.27B | |
$19.42 | |
$40.65 | |
$4.93 | |
$19.34 | |
332.70K | |
865.14K | |
-- | |
$40.65 | |
$13.35 | |
-- | |
-- |
Tyra Biosciences, Inc. (TYRA) Stock Price Today
Tyra Biosciences, Inc. (TYRA) is currently trading at $20.45 as of 2026-10-20 19:41:00, up 5.74% ($1.11) from the previous close of $19.34
During today's regular trading session, TYRA has traded between $4.93 and $40.65, with a trading volume of 332.70K shares. The current price is near the middle of today's range.
Tyra Biosciences, Inc. (TYRA) 7-Day Stock Price Change
Over the past seven days, Tyra Biosciences, Inc. (TYRA) moved from $19.94 to $20.45, representing a gain of 2.56% ($0.51).
The stock traded between $18.25 and $22.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 553.75 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
TYRA 52-Week Price Position
Position in Range: 26.0%
TYRA is currently trading at $20.45, placing it 26.0% of the way from its 52-week low of $13.35 to its 52-week high of $40.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Tyra Biosciences, Inc. (TYRA)?
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Tyra Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 87 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Tyra Biosciences, Inc. (TYRA) Stock on MEXC
Eligible investors can buy real shares of Tyra Biosciences, Inc. (TYRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Tyra Biosciences, Inc. (TYRA) stock price today?
2.Is TYRA stock going up or down today?
3.What is TYRA pre-market price?
4.What is TYRA after-hours price?
5.Is TYRA stock trading now?
6.Where does TYRA sit relative to its 52-week high and low?
7.What sector is Tyra Biosciences, Inc. in?
8.What is Tyra Biosciences, Inc.'s market capitalization and where is it listed?
9.How is TYRA valued in terms of P/E ratio and EPS?
10.Does Tyra Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
TYRA Stock Calculator
Estimate the value between TYRA shares and USD.
TYRA Shares to USD
1.00 TYRA shares = 20.45 USD
Calculations are estimates based on the latest available price and are for reference only.


